WSR 16-06-023
[Filed February 22, 2016, 8:04 a.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 16-01-009.
Title of Rule and Other Identifying Information: WAC 260-70-640 Permitted medication.
Hearing Location(s): Auburn City Council Chambers, 25 West Main, Auburn, WA 98002, on April 8, 2016, at 9:30 a.m.
Date of Intended Adoption: April 8, 2016.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, e-mail, fax (360) 459-6461, by April 5, 2016.
Assistance for Persons with Disabilities: Contact Patty Brown by April 5, 2016, TTY (360) 459-6462.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: Clarifies when multiple NSAIDs may be permitted in a post race sample.
Reasons Supporting Proposal: Prior language was confusing and lead to discussions on how to make it clearer if more than one NSAID is detected in a post race sample.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: [Horse racing commission], governmental.
Name of Agency Personnel Responsible for Drafting, Implementation, and Enforcement: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, (360) 459-6462.
No small business economic impact statement has been prepared under chapter 19.85 RCW. Not applicable.
A cost-benefit analysis is not required under RCW 34.05.328. Not applicable.
February 22, 2016
Douglas L. Moore
Executive Secretary
AMENDATORY SECTION (Amending WSR 12-07-005, filed 3/9/12, effective 4/9/12)
WAC 260-70-640 Permitted medication.
Trainers using permitted medication in the care of their horses are subject to all rules governing such medications. Failure to administer permitted medication to a horse on a program of permitted medication is a violation of these rules.
(1) The use of one of three approved nonsteroidal anti-inflammatory drugs (NSAIDs) is permitted under the following conditions:
(a) The drug may not exceed the following permitted serum or plasma threshold concentrations, which are consistent with administration by a single intravenous injection at least twenty-four hours before the post time for the race in which the horse is entered:
(i) Phenylbutazone - 5 micrograms per milliliter in overnight and nongraded stakes races, and 2 micrograms per milliliter in graded stakes races;
(ii) Flunixin - 50 nanograms per milliliter;
(iii) Ketoprofen - 10 nanograms per milliliter.
(b) No NSAID, including the approved NSAIDs listed in this rule, may be administered within the twenty-four hours before post time for the race in which the horse is entered.
(c) The presence of ((more than one of the three)) a second approved NSAID((s, with the exception of)) will not be considered a violation if the approved NSAID is not over the secondary threshold as follows:
(i) Phenylbutazone ((in a concentration below 1 microgram per milliliter of serum or plasma or)) - 1 mcg per milliliter;
(ii) Flunixin - 3 ng per milliliter;
(iii) Ketoprofen - 1 ng per milliliter.
(d) Any unapproved NSAID in the post-race serum or plasma sample is not permitted. The use of all but one of the approved NSAIDs must be discontinued at least forty-eight hours before the post time for the race in which the horse is entered.
(2) Any horse to which a NSAID has been administered is subject to having a blood and/or urine sample(s) taken at the direction of an official veterinarian to determine the quantitative NSAID level(s) and/or the presence of other drugs which may be present in the blood or urine sample(s).